INTRODUCTION
Improving our understanding of the intracellular environment in which the pathogen Mycobacterium tuberculosis lives is one approach to identifying targets for the development of new rational control measures. A number of observations point to the importance of fatty acids as carbon and energy sources in members of the M. tuberculosis complex (Fig. 1) . Thus a mutant lacking isocitrate lyase, part of the glyoxylate shunt, has a reduced persistence phenotype in a mouse model (McKinney et al., 2000) . In the related Mycobacterium bovis, the pyruvate kinase gene is non-functional (Garnier et al., 2003) , so the glycolysis pathway is inactive. In M. bovis BCG, a mutant lacking pckA, the gene for phosphoenolpyruvate carboxykinase (one of the two non-reversible steps in gluconeogenesis), is attenuated in vivo (Liu et al., 2003) , and the pckA gene is up-regulated during growth in macrophages (Dubnau et al., 2002) . Another study showed that M. tuberculosis cells present in sputum contain lipophilic inclusions (Garton et al., 2002) , while Mycobacterium microti uses palmitic acid preferentially over simple carbon sources (Wheeler & Ratledge, 1988) . Finally, the TraSH methodology that identifies mutations responsible for poor growth in bacteria following transposon mutagenesis (Sassetti & Rubin, 2003) identified a number of fatty acid degradation genes, the glyoxylate shunt genes, and pckA as being essential in vivo. Taken together, these findings emphasize the importance of the glyoxylate shunt and gluconeogenesis in using the carbon from fatty acids for biosynthesis of the sugars that are abundant in the cell wall and glycolipids of mycobacteria.
The second irreversible step in gluconeogenesis is fructose 1, EC 3.1.3.11) . Although the completion of the M. tuberculosis genome sequence allowed the identification of genes that were predicted to encode enzymes for most central metabolic pathways (Cole et al., 1998) , no FBPase was assigned. Four classes of FBPases have been identified based on primary structure (Rittmann et al., 2003) . These are Escherichia coli Fbp-like (class I) (Sedivy et al., 1984) , E. coli GlpX-like (class II) (Donahue et al., 2000) , Bacillus subtilis-like (class III) (Fujita et al., 1998) and dual function FBPase-inositol monophosphate phosphatases (class IV) (Verhees et al., 2002) . A fifth class has been identified in the Archaea, which may represent the 'true' FBPase in these organisms (Rashid et al., 2002) . In E. coli, the major FBPase is a class I member encoded by the fbp gene, for which there is no detectable homologue in the actinomycetes. It has recently been reported that a minor class II FBPase is encoded in E. coli by the glpX gene, which is part of the glycerol 3-phosphate regulon (Donahue et al., 2000) . The protein encoded by the M. tuberculosis Rv1099c gene shows 43 % identity to E. coli GlpX. In this work, the Rv1099c gene was cloned. Results of genetic and biochemical analyses revealed that the Rv1099c gene is likely to encode the missing mycobacterial FBPase.
METHODS
Bacterial strains and plasmids. E. coli JLD2404 (Dfbp287), JLD2402 (glpX : : Spc R Dfbp287), and JB108 (BL21[lDE3 (lacUV5-T7 gene1)] Dfbp287) have been described before (Donahue et al., 2000) . M. tuberculosis H37Rv was used for RNA analysis. Plasmid vectors used were pET15b (p T7 -His-tag; Novagen) and pGEX-KG (p tac -GST; AmershamPharmacia). In pGEX-KG, the glutathione S-transferase (GST) fusion protein is induced directly by IPTG, while in pET15-b, the fusion protein is expressed by an IPTG-inducible T7 RNA polymerase encoded by a lysogenic phage. pFM142 and pFM149 carry M. tuberculosis Rv1099c cloned into pET15-b and pGEX-KG, respectively, and are described in this study.
E. coli culture conditions. Strains were grown in Luria broth (LB) supplemented with antibiotics as needed or in M9 minimal media (Sambrook et al., 1989) containing 0?2 % glucose or 0?4 % glycerol. E. coli DH5a (Life Technologies) was used for all plasmid constructions.
Cloning of Rv1099c. M. tuberculosis Rv1099c was cloned into expression vectors using the Tuberculist-predicted start codon (position 35 in Fig. 2 ). The Rv1099c coding sequence was amplified by PCR using primers Rv1099c-NdeI (GGAATTCCATATGGAGCTGGTCCGGGT) and Rv1099c-XhoI (TGACTCGAGGGCAATGGGTACACG). These primers introduced an NdeI site at the 59 end and an XhoI at the 39 end to allow the gene to be cloned in-frame into the expression vector pET-15b. Primers Rv1099c-PvuII (GGATCAGCTGATGGAGCTGGT-CCGGGT) and Rv1099c-EcoRI (CGGAATTCGGGCAATGGGTAC-ACG) were used to introduce a PvuII site at the 59 end and an EcoRI at the 39 end to allow the gene to be cloned in-frame into the expression vector pGEX-KG. The primers were each used at 300 nM final concentration. PCR was carried out using the Expand High Fidelity PCR system (Boehringer Mannheim) with M. tuberculosis DNA as the template and DMSO at 2 %. The temperature cycle used was: an initial 3 min at 94 uC to denature high-G+C DNA; 10 cycles of 45 s at 94 uC, 1 min at 63 uC and 1 min at 72 uC; 25 cycles of 45 s at 94 uC, 1 min at 63 uC and 1 min at 72uC (this last increasing by 20 s per cycle); and finally an extension step of 7 min at 72 uC to complete primer extension. The PCR products were cleaved with the appropriate restriction enzymes and cloned into the vectors pET-15b or pGEX-KG. In this way, plasmids expressing the M. tuberculosis Rv1099c gene were generated, as both His-tag and GST-fusion constructs.
Enzyme preparation and assay. Strains of E. coli were grown with aeration at 37 uC in LB medium to the exponential phase, induced with IPTG (0?1 mM), and incubated with shaking at room temperature for 3 h. Bacteria were harvested by centrifugation, washed and the pellets were resuspended in 2-4 ml 25 mM Tris/HCl (pH 7?3) containing 2 mM dithiothreitol. This suspension was sonicated for 40 s at 50 % amplitude with a 5 mm diameter probe (Sonics & Materials VibraCell), and the sonicate clarified by centrifugation (12 000 g, 5 min). Virtually all enzyme activity was in the supernatant fractions. GST activity was assayed using the AmershamPharmacia GST detection module according to the manufacturer's instructions. FBPase activity was assayed at 37 uC by measuring the fructose 6-phosphate produced in an assay coupled to phosphoglucoisomerase and glucose-6-phosphate dehydrogenase by following the production of NADPH (Rashid et al., 2002) . Preliminary attempts to purify fusion proteins using HiTrap Chelating HP or GS Trap FF columns (AmershamPharmacia) according to the manufacturer's instructions resulted in loss of FBPase activity. Therefore, clarified cell extracts were used for the enzyme work described below. All enzyme extracts and preparations were desalted using AmershamPharmacia PM10 columns equilibrated and eluted with 25 mM Tris/HCl (pH 7?3) containing 2 mM dithioerythritol according to the manufacturer's instructions.
To estimate the K m , the concentration of fructose 1,6-bisphosphate was varied from 2 mM (the concentration routinely used elsewhere; see Rashid et al., 2002) down to 3 mM. Fructose 1,6-bisphosphate was used at 20 mM in all experiments designed to test for potential inhibitors, including LiCl, that were included at the concentrations mentioned in Results. The potential inhibitors were mixed with extracts and incubated for 5 min before adding substrate to start the reaction.
Quantitative PCR. RNA was prepared from an exponential (7-day) rolling culture of M. tuberculosis H37Rv (Betts et al., 2002) , and cDNA synthesis was carried out using Superscript II (Invitrogen) according to the manufacturer's protocol. Real-time quantitative PCR (RTq-PCR) reactions were set up using the DyNAmo SYBR Green qPCR kit (MJ Research) and RTq-PCR was performed using the DNA Engine Opticon 2 System (Genetic Research Instrumentation). Reactions containing 16 DNA Master SYBR Green I mix, 1 ml cDNA product and 0?4 mM of each primer in 20 ml were set up on ice. Samples were heated to 95 uC for 10 min before cycling for 35 cycles of 95 uC for 30 s, 60 uC (Rv1099c) or 62 uC (sigA) for 20 s, and 72 uC for 20 s. Fluorescence was captured at the end of each cycle after heating to 80 uC to ensure the denaturation of primerdimers. The experiment was repeated three times using cDNA from each of two independent RNA preparations. 
RESULTS

Comparison of glpX orthologues and their genomic contexts
The Rv1099c gene is homologous to E. coli glpX. An alignment of predicted GlpX proteins from several actinomycetes, as well as E. coli, is shown in Fig. 2 . We suggest that Rv1099c is a class II FBPase; it has 43 % identity (62 % similarity) to E. coli GlpX, and low similarity to members of the other FBPase classes. In the Clusters of Orthologous Groups (COGs) database (Tatusov et al., 2001) , Rv1099c is clustered with other class II (GlpX-like) FBPases. (Thompson et al., 1994) using default settings. The CLUSTALW alignment was shaded using the CHROMA program (Goodstadt & Ponting, 2001) . Fully conserved residues are in white on a black background; other residues are shaded according to their physicochemical properties. Invariant positions are indicated by asterisks (*) below the alignment, while highly conserved and weakly conserved positions are indicated by colons and periods, respectively. The Eco sequence was obtained from SWISS-PROT (accession no. P28860), the Cgl and Sco sequences were obtained from GenBank (accession nos 19552240 and 21223420 respectively), the Mtb sequence was obtained from the Tuberculist server (http://genolist.pasteur.fr/TubercuList/; gene name Rv1099c), the Mlp sequence was obtained from the Leproma server (http://genolist.pasteur.fr/Leproma/; gene name ML1946), the Msm and Mav sequences were derived from unpublished genomic sequences obtained from The Institute for Genomic Research website (http://www.tigr.org/), and the Cdi sequence was obtained from the Sanger Centre (CerdenoTarraga et al., 2003) (also available from GenBank: accession no. 38199795). The exact start residue of the proteins is known only for Synecococcus PCC7942 (Tamoi et al., 1996) (which corresponds to the predicted E. coli start), and for C. glutamicum (Rittmann et al., 2003) . For all other proteins, we have predicted the start codon, which may not necessarily be the same as that given when using the aforementioned accession numbers, on the basis of mutual homologies. The (probably incorrect) start position for the Mtb and Mlp sequences (as described in the Tuberculist and Leproma databases) is indicated by an 'M'. The location of IMP1 Prosite motif (http://www.expasy.ch/prosite accession no. PS00629), is indicated by a bar above the alignment. The motif is nearly present in the mycobacterial putative class II FBPases, as can be seen from the list of valid motif residues shown under the alignment (x=any residue valid): only one mismatch is found (position 121, underlined). However, there are two mismatches to the Sco sequence, and three mismatches to the Eco GlpX, the Cgl Fbp and the Cdi putative FBPase II.
Rv1099c is the first gene in a cluster of three genes that we predict is an operon (see Fig. 3 ). The second gene, fum (30 bp downstream), encodes the only predicted fumarase in the genome, which is presumed to function in the citric acid cycle (Fig. 1) . Its location next to Rv1099c is conserved in all the sequenced mycobacterial genomes, and suggests a functional relationship between these two genes. Rv1097c, the start of which overlaps the end of fum in M. tuberculosis, is a putative Gly/Pro-rich membrane protein with unknown function that is not conserved in other species. A conserved hypothetical gene, Rv1100, is transcribed divergently from this putative operon, and its conserved synteny in other genomes is suggestive of a related function.
The intergenic region between the divergently transcribed Rv1099c and Rv1100 genes is currently annotated at 100 bp. We suggest, however, that the start of the coding sequence (MELV...) predicted for Mtb Rv1099c in GenBank (accession no. 15608239) and in Tuberculist Release 5 (http:// genolist.pasteur.fr/TubercuList/) is misannotated (Fig. 2) , because the homology with E. coli GlpX extends several amino acids upstream to a different methionine, and homology to the Corynebacterium glutamicum Fbp (confusingly the homologue of E. coli GlpX, and not of E. coli Fbp, i.e. a class II FBPase) extends further still. Critically, experimental analysis of the C. glutamicum protein confirms that this conserved region is translated (Rittmann et al., 2003) , contrary to the assignment in the published sequence. This would mean that the M. tuberculosis protein is likely to start 66 (VSAH...) or 102 (MTAE...) base pairs upstream. Alignment with the Mycobacterium avium sequence, which has a potential start analogous to the 2102 but not the 266 start, suggests that the 2102 start is correct. Similarly, we predict the Mycobacterium leprae start codon to be 57 bases upstream of that predicted by the Leproma database Release 2 (http://genolist.pasteur.fr/ Leproma/). Mycobacterium smegmatis has an analogous methionine to the start codon of the C. glutamicum.
This reassignment of the start of M. tuberculosis Rv1099c affects the predicted start for the divergently transcribed Rv1100, as it overlaps the newly assigned start codon for Rv1099c. While it is possible that both promoters lie within coding sequences, it is more likely that there is an intergenic gap. The corynebacterial Rv1100 homologues are located further upstream of glpX (~200 bp), and have only one potential start site upstream of conserved regions (C. glutamicum: VAEK...). M. tuberculosis Rv1100 has a potential GTG start codon in a similar position in the aligned proteins; this aligns with the likely start in M. smegmatis (MTTQ...), and we propose that this is the genuine start codon. This would leave the intergenic gap between Rv1099c and Rv1100 at 57 bp. We suggest new translational starts for the M. leprae homologues using similar logic: glpX (ML1946) will start 81 bp upstream of the current assignment at base 2332629 (old start, MELV...; new start, MTAE...), and the Rv1100 orthologue ML1945 will start 84 bp of the current assignment at base 2332549 downstream (old start, MVND...; new start, VTFE...).
Complementation of E. coli mutants
It is possible to test for FBPase activity by genetic complementation, as an E. coli fbp mutant is unable to grow on medium with glycerol as sole carbon source (Donahue et al., 2000) . We therefore cloned Rv1099c into two expression vectors, so that it would be expressed either with a short N-terminal His-tag (pFM142), or fused to the C-terminal end of GST (pFM149). These constructs were introduced into E. coli strains JLD2402, which lacks both fbp and glpX, and JLD2404, which lacks only fbp. Antibioticresistant transformants were selected and then plated onto minimal agar plates containing glucose or glycerol as carbon source, and IPTG to induce expression of Rv1099c. All of these strains grew on glucose agar, whereas the control strains only grew on glycerol agar (results with JLD2402 and pFM149 are shown in Fig. 4) . Complementation was not expected from the pET15b-based clone pFM142, because of the lack of a host T7 polymerase gene, but was detected; our experience is that this can occur due to read-through from other promoters. These results confirm that Rv1099c has FBPase activity. For historical reasons, the clones were made using the start site predicted by Tuberculist. The fact we obtained activity indicates that if the protein does have an extended N-terminus as we predict, this region is not critical for function.
FBPase activity in complemented E. coli mutants pFM142 and pFM149 were transformed into E. coli JB108, a BL21(lDE3)-based strain that lacks fbp, and allows both pGEX and pET15-b-based constructs to be expressed. A spectrophotometric coupled-enzyme assay was used to measure the FBPase activity in cell-free extracts ( Table 1) . The E. coli JB108 (Dfbp) host gave low background levels, and introduction of pFM142 or pFM149 resulted in elevated levels of FBPase. Note that although strain JB108 has a functional chromosomal glpX gene, we showed that FBPase levels in strain JLD2402 (Dfbp DglpX) were not significantly different from those in strain JLD2404 (Dfbp) ( Table 1) , supporting earlier observations that although E. coli GlpX has FBPase activity, the gene is expressed at low levels (Donahue et al., 2000) .
We determined that the K m of the M. tuberculosis recombinant enzyme for fructose 1,6-bisphosphate was 15 mM (three determinations, range 12-17 mM), using E. coli cell-free extracts. The K m values obtained were similar for the two types of fusion protein made in this study, suggesting that the type of fusion construct used did not affect the affinity of the FBPase for its substrate. The effects of phosphoenolpyruvate, AMP, ADP, citrate and Li + on the FBPase activity of both the GST fusion and the Histagged proteins were tested. None of the metabolites had any effect up to 1 mM, but 1?1 mM Li + gave 50 % inhibition and 10 mM Li + gave over 90 % inhibition (not shown).
Gene expression levels in M. tuberculosis
We carried out RTq-PCR experiments to determine the level of expression of Rv1099c mRNA in exponential cultures of M. tuberculosis in Middlebrook 7H9 medium containing OADC supplement and Tween 80. Expression levels were normalized to those of sigA mRNA, and calculated based on the RNA used for reverse transcription. We showed that in mid-exponential-phase growth in supplemented Middlebrook 7H9 medium (which contains both glucose and Tween 80 as carbon sources), the level of Rv1099c mRNA is 0?49 (95 % confidence interval 0?39-0?63) that of sigA.
DISCUSSION
Although no FBPase was annotated in the genomes of any of the actinomycetes when this work started, the ability of these organisms to grow on gluconeogenic substrates such as fatty acids or glycerol requires FBPase to be present in order to provide the hexose needed for synthesis of their abundant cell envelope glycans and mannolipids. In other organisms, particularly the Archaea, where no FBPase was annotated during whole-genome analyses, other members of the carbohydrate phosphatase superfamily (http://scop. mrc-lmb.cam.ac.uk/scop/; release 1.65) have been shown to encode active FBPases. In M. tuberculosis, this superfamily comprises the impA, suhB, impC (Rv3137c), cysQ and Rv1099c genes.
We show here that M. tuberculosis Rv1099c has FBPase activity with saturable kinetics, and a K m at 15 mM that is similar to the affinity of bacterial class II FBPases for fructose bisphosphate. For example, the C. glutamicum enzyme has a K m of 14 mM and the E. coli GlpX has a K m of 35 mM. Lithium inhibits by interfering with the Mg 2+ binding site of sugar phosphatases (Chen & Roberts, 1998) , so its effect on the M. tuberculosis FBPase activity is consistent with this. The lack of effect of any of the intermediates is surprising as it is expected that GlpX needs to be regulated, for instance to avoid futile cycling when phosphofructokinase is active. However, their effects need to be investigated further on purified, possibly cleaved fusion protein before drawing any firm conclusions about regulation.
We suggest that Rv1099c may be the major FBPase of M. tuberculosis; this is supported by the recent report where the GlpX homologue of C. glutamicum was characterized (Rittmann et al., 2003) . The authors showed that it contained FBPase activity, and demonstrated that a mutant lacked any detectable FBPase activity. The corynebacterial glpX mutant was incapable of growth on gluconeogenic substrates, which substantiates the observation that no other FBPase is predicted by the genome sequence of this organism. The C. glutamicum gene was accordingly named fbp; we, however, propose that Rv1099c be called glpX in order to avoid the implication that it is orthologous to the E. coli fbp gene; the glpX name is also used in the COGs database.
Interestingly, all the mycobacterial class II FBPases shown in Fig. 2 have a near-perfect Prosite (http://www.expasy.ch/ prosite) inositol monophosphate phosphatase IMP1 motif (PS00629), although they have no IMP2 motif (PS00630). This may suggest a closer homology of the mycobacterial class II FBPases to IMPases than other members of the family. No activity with inositol 1-phosphate could be attributed to Rv1099c under the conditions examined (data not shown).
We demonstrated that Rv1099c is expressed in the cell. mRNA levels approximately half of the level of sigA, the major sigma factor of the cell, were detected. The fact that it is expressed is also indicated by the identification of the protein in 2D-PAGE analysis (http://www.mpiib-berlin. mpg.de/2D-PAGE/EBP-PAGE/index.html).
Support for a key biological role for the M. tuberculosis glpX gene comes from independent concurrent research using a genome-wide transposon-based method (TraSH) for identifying genes that are required for growth in different conditions (Sassetti et al., 2001; Sassetti & Rubin, 2003) . The data suggest that the fum gene (Figs 1 and 3) is an essential gene for axenic growth in the presence of both glycolytic (glucose) and gluconeogenic (oleic acid) carbon sources together (Middlebrook 7H9+OADC+Tween 80). Mutants deficient in Rv1100 (which is conserved syntenically with Rv1099c in mycobacteria and corynebacteria) grew slowly, but it appeared that mutants deficient in Rv1099c grew normally. However, a comparison between axenic and in vivo growth showed that mutants in Rv1099c were among the most severely attenuated in a mouse model. This was confirmed in separate experiments showing that an Rv1099c transposon mutant is highly attenuated in vivo (Sassetti & Rubin, 2003) . The extreme attenuation of the glpX mutant is consistent with the essential role of gluconeogenesis for conversion of lipid carbon into cell wall glycan (Fig. 1) . These data, together with the demonstration that a C. glutamicum fbp mutant has lost all detectable FBPase activity, suggest that glpX encodes the major FBPase in M. tuberculosis.
